Frequently Asked Questions

Get answers to common questions about Weight Loss (Semaglutide / TIrzepatide Injection).

They mimic gut hormones that signal fullness to the brain, slowing gastric emptying and reducing hunger. This leads to lower caloric intake, helping you lose weight when combined with diet and exercise under medical supervision. Effects vary by individual and dose.

Your clinician reviews medical history, medications, and weight goals, performs vital assessments, and discusses treatment options, risks, and benefits. A personalized dosing plan and lifestyle support are outlined, and follow-up scheduling ensures safe progress and monitoring.

Mild gastrointestinal symptoms like nausea, constipation, or diarrhea are most common, especially during dose escalation. Symptoms often decrease over time and can be managed with gradual dosing increases, dietary adjustments, and clinician guidance. Serious reactions are rare but reported.

Many patients notice reduced appetite within weeks and measurable weight loss within one to three months. Speed depends on dose, adherence, lifestyle, and individual metabolism. Your provider will monitor progress and adjust the plan to promote steady, sustainable weight reduction.

Semaglutide and Tirzepatide are useful for many people with type two diabetes and can improve glucose control. Safety and dosing require careful medical review, especially for those on insulin or sulfonylureas, to avoid hypoglycemia and ensure proper monitoring.

Some weight regain can occur without ongoing treatment and lifestyle support. Long-term success requires gradual habit changes, nutrition, activity, and maintenance strategies. Your medical team creates a transition plan, behavioral tools, and follow-up to sustain weight loss after stopping medication.